Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Description
Brief Summary
This study examines information from patients with prostate cancer that may have spread from
where it first started to nearby tissue, lymph nodes, or distant parts of the body
(advanced). By collecting biological samples (like blood, urine, and tissue), and health
information (such as treatment, diet, and quality of life) researchers hope to learn more
about prostate cancer and ways to improve outcomes in the future.
Detailed Description
PRIMARY OBJECTIVE:
I. To create an annotated biorepository with prospectively collected blood and urine samples
from men with advanced prostate cancer.
OUTLINE: This is an observational study.
Patients undergo blood and urine sample collection, complete surveys, and have their medical
records reviewed on study.
Phase
N/AInclusion and Exclusion Criteria
- * Men of all racial and ethnic groups 18 years of age or older
- Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
- Prior participation on clinical trials is allowed
- * Inability to give informed consent
Sites
Please contact the trial administrator to learn more about where you can participate in this trial. Please use the contact form on the right side.
Powered by
SC CTSI